Ameriprise Financial Inc Pacira Bio Sciences, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 129,664 shares of PCRX stock, worth $2.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

129,664

Previous 187,957 31.01%

Holding current value

$2.12 Million

Previous $5.38 Million 63.7%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$11.7 - $28.46 $682,028 - $1.66 Million	-58,293 Reduced 31.01%	129,664 $1.95 Million
Q2 2024 Aug 14, 2024	SELL	$25.5 - $31.51 $460,402 - $568,913	-18,055 Reduced 8.76%	187,957 $5.38 Million
Q1 2024 May 15, 2024	SELL	$27.7 - $35.48 $238,690 - $305,731	-8,617 Reduced 4.01%	206,012 $6.02 Million
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $303,074 - $395,079	-11,515 Reduced 5.09%	214,629 $7.24 Million
Q3 2023 Nov 14, 2023	SELL	$30.68 - $40.09 $612,311 - $800,116	-19,958 Reduced 8.11%	226,144 $6.94 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $47.5 $464,647 - $611,040	-12,864 Reduced 4.97%	246,102 $9.86 Million
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $69,532 - $84,894	1,957 Added 0.76%	258,966 $10.6 Million
Q4 2022 Feb 14, 2023	SELL	$38.19 - $57.45 $1.99 Million - $3 Million	-52,227 Reduced 16.89%	257,009 $9.92 Million
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $118,261 - $135,918	-2,308 Reduced 0.74%	309,236 $16.4 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $2.8 Million - $4.45 Million	54,457 Added 21.18%	311,544 $18.2 Million
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $25,932 - $33,043	432 Added 0.17%	257,087 $19.6 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $1.98 Million - $2.57 Million	-41,279 Reduced 13.86%	256,655 $15.4 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $2.26 Million - $2.54 Million	-41,425 Reduced 12.21%	297,934 $16.7 Million
Q2 2021 Aug 16, 2021	SELL	$59.18 - $69.99 $286,963 - $339,381	-4,849 Reduced 1.41%	339,359 $20.6 Million
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $4.43 Million - $5.89 Million	74,674 Added 27.7%	344,208 $24.1 Million
Q4 2020 Feb 12, 2021	BUY	$50.47 - $66.26 $1.51 Million - $1.98 Million	29,899 Added 12.48%	269,534 $16.1 Million
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $280,066 - $339,507	5,389 Added 2.3%	239,635 $14.4 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $582,335 - $992,050	18,907 Added 8.78%	234,246 $12.3 Million
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $59,640 - $106,470	-2,100 Reduced 0.97%	215,339 $7.22 Million
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $137,796 - $177,719	-3,795 Reduced 1.72%	217,439 $9.85 Million
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $7.89 Million - $9.95 Million	221,234 New	221,234 $8.42 Million
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $3.37 Million - $4.42 Million	-92,040 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $29,795 - $34,452	-817 Reduced 0.88%	92,040 $3.5 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $1.83 Million - $2.3 Million	44,181 Added 90.77%	92,857 $4 Million
Q3 2018 Nov 14, 2018	SELL	$32.85 - $52.0 $63,367 - $100,308	-1,929 Reduced 3.81%	48,676 $2.39 Million
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $3.25 Million - $4.71 Million	-118,263 Reduced 70.03%	50,605 $1.62 Million
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $3.62 Million - $5.6 Million	-120,716 Reduced 41.69%	168,868 $5.26 Million
Q4 2017 Feb 12, 2018	SELL	$31.85 - $46.95 $22,103 - $32,583	-694 Reduced 0.24%	289,584 $13.2 Million
Q3 2017 Nov 07, 2017	BUY	$35.7 - $39.5 $10.4 Million - $11.5 Million	290,278	290,278 $10.9 Million

Others Institutions Holding PCRX

# of Institutions

266

Shares Held

50.7M

Call Options Held

347K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $750M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Pacira Bio Sciences, Inc. Transaction History